Pediatric glaucoma, also known as childhood glaucoma, is a disease that leads to blindness in children due to damage to the optic nerve. Primary congenital glaucoma (PCG) shares symptoms and characteristics with ocular hypertension. If left untreated, it can result in blindness. However, timely diagnosis and treatment can help protect vision.

World Glaucoma Week

World Glaucoma Week, observed annually from March 9–15, is organized by the World Glaucoma Association. This global initiative purports to raise awareness about glaucoma, including pediatric glaucoma.

Classification of Pediatric Glaucoma

As per the Childhood Glaucoma Research Network (CGRN) classification system, pediatric glaucoma includes various conditions that fall under two main subtypes based on their cause: primary and secondary glaucomas. The CGRN is a global organization that collaborates with leading physicians and patients to conduct research on pediatric glaucoma. The CGRN classification provides a foundational understanding for physicians to deliver appropriate treatment and care.

• Primary Glaucomas: This category includes congenital and developmental glaucomas, which share similar symptoms, syndromes, and systemic abnormalities.
• Secondary Glaucomas: These result from causative pathologies such as uveitis or congenital cataracts. 

Incidence of Pediatric Glaucoma

The incidence of primary congenital glaucoma varies significantly worldwide. In Western nations, it is estimated to affect approximately 1 in 20,000 children, whereas, in certain isolated populations, such as in India or the gypsy subpopulation of Slovakia, the prevalence is notably higher, with an incidence of around 1 in 3,300 and 1 in 1,250, respectively. Unlike adult-onset glaucoma, pediatric glaucoma involves distinct pathologies, including progressive optic nerve damage and elevated intraocular pressure (IOP), requiring unique clinical approaches and surgical techniques.

Challenges in Treatment and Care

A significant challenge in managing pediatric glaucoma is the shortage of surgeons specifically trained in treating this condition. While adult-onset glaucoma and pediatric glaucoma share a name, they demand entirely different treatment strategies.

• Surgical Interventions: Primary congenital glaucoma is often treated with angle surgeries, which have a 70–90% success rate in children aged 1–2 years. Success rates decrease significantly in older patients and those with developmental glaucoma.
• Mechanism of Surgery: Pediatric glaucoma surgery aims to reduce IOP by either decreasing fluid production or increasing fluid outflow. However, surgery can be challenging due to the variety and complexity of causes, anatomical differences, and the higher likelihood of complications and treatment failure in the pediatric patient populace.
• Access to Care: Even in regions with advanced ophthalmic facilities, many children lack timely access to specialists with the necessary training and tools for effective treatment.

Advances and Global Solutions

Due to the limited availability of specialized care units for rare diseases like PCG, skilled pediatric glaucoma specialists often travel globally to deliver treatment. This effort has helped preserve the eyesight of many children worldwide. Vision impairment and blindness from glaucoma also have far-reaching socioeconomic impacts, particularly in developing countries.

Recent research has focused on ocular genetics, improved screening techniques, and related syndromes to improve the clinical management of pediatric glaucoma.

Conclusion

Pediatric glaucoma remains a significant challenge for eye care professionals, particularly in developing countries. Unlike conditions such as cataracts, managing glaucoma requires long-term follow-up, periodic medication adjustments, and consistent care. Initiatives that enhance global access to specialized pediatric glaucoma treatment are vital for reducing blindness and improving outcomes for children and infants worldwide.